Impact of Oral Diets on Postoperative Fluid Collection (BC1)

October 5, 2021 updated by: Stanislaw Klek, Stanley Dudrick's Memorial Hospital

Impact of Preoperative Oral Diets on Postoperative Fluid Collection After Axillary Lymphadenectomy

Patients after the surgical removal of axillary lymphnodes suffers from prolonged fluid collections. The aim of the study is to assess the impact of oral immunonutrition and high-protein diets on the reduction of fluid collection.

Study Overview

Detailed Description

Patients after the surgical removal of axillary lymphnodes suffers from prolonged fluid collections, which requires either prolonged drainage or multiple punctuations. The aim of the study is to assess the impact of oral immunonutrition and high-protein diets on the reduction of fluid collection.

Study Type

Interventional

Enrollment (Anticipated)

400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Skawina, Poland, 32-050
        • Recruiting
        • Stanley Dudrick's Memorial Hospital
        • Contact:
        • Principal Investigator:
          • Stanislaw Klek, Assoc. Prof.
    • Malopolska
      • Kraków, Malopolska, Poland, 31-115

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • confirmed breast cancer or melanoma
  • scheduled surgery with axillary lymph nodes resection
  • informed consent
  • eligible for surgery

Exclusion Criteria:

  • benign disease
  • no consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: No intervention
Experimental: Immunonutrition
Oral immunonutrition containing arginine, omega-PUFAs and antioxidants
Oral immunonutrition containing arginine, omega-PUFAs and antioxidants
Active Comparator: High-protein diet
Oral nutrition with high-protein content
Oral nutrition with high-protein content
Active Comparator: Standard nutrition
Oral nutrition with standard ingredients
Oral nutrition with standard ingredients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fluid collection
Time Frame: 6 months
The volume of fluid collection after lymph nodes resection expressed in mililiters
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2021

Primary Completion (Anticipated)

January 31, 2023

Study Completion (Anticipated)

March 31, 2023

Study Registration Dates

First Submitted

September 25, 2021

First Submitted That Met QC Criteria

September 25, 2021

First Posted (Actual)

October 6, 2021

Study Record Updates

Last Update Posted (Actual)

October 13, 2021

Last Update Submitted That Met QC Criteria

October 5, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BC1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Clinical Trials on Immunonutrition

3
Subscribe